The Multidisciplinary Approach to GLP-1 RA and SGLT2 Inhibitors in Cardiometabolic Care: A New Era for Patients with Diabetes and Heart Disease

Key Result

A multidisciplinary approach to GLP-1 receptor agonists and SGLT2 inhibitors marks a new era in cardiometabolic care for patients with diabetes and heart disease.

Main Result

Absolute Event Rate: 0% vs 0%

Abstract

Editorial ....

Mark Helpful

Bookmark

Relay

View Full Paper

Mark Helpful

Bookmark

Relay

View Full Paper

Cite This Study

Lucà et al. (Tue,) reported a other. A multidisciplinary approach to GLP-1 receptor agonists and SGLT2 inhibitors marks a new era in cardiometabolic care for patients with diabetes and heart disease.

synapsesocial.com/papers/6a0de0981e1a6dfdb4bae54c https://doi.org/https://doi.org/10.3390/jcm14144834

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Glucagon‐like peptide 1 receptor agonists in patients with type 2 diabetes with and without chronic heart failure: A meta‐analysis of randomized placebo‐controlled outcome trials2023 · 60 citations
2Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes2021 · 770 citations
3Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy2001 · 7,481 citations
4Kidney Disease and Increased Mortality Risk in Type 2 Diabetes2013 · 1,260 citations
5Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 Diabetes2024 · 31 citations